Chinese Journal of Pharmacovigilance ›› 2024, Vol. 21 ›› Issue (11): 1209-1215.
DOI: 10.19803/j.1672-8629.20240449
Previous Articles Next Articles
LIU Shujia1, ZHANG Xiaomeng1,2, CHEN Siying1, CAI Haili1, ZHANG Bing1,2,*
Received:
2024-07-04
Online:
2024-11-15
Published:
2024-11-20
CLC Number:
LIU Shujia, ZHANG Xiaomeng, CHEN Siying, CAI Haili, ZHANG Bing. Systematic Evaluation of Cardiotoxicity of Chinese Herbal Compounds for Breast Cancer Chemotherapy[J]. Chinese Journal of Pharmacovigilance, 2024, 21(11): 1209-1215.
[1] YUAN JJ, YANG B, KANG LR et al. The Mechanism of Action of Statins in Preventing Myocardial Injury after Anthracycline Chemotherapy[J]. Chinese Journal of Gerontology(中国老年学杂志), 2021, 41(9): 2012-2015. [2] ZHAO XN, ZHANG XL, SHU Z, et al.Research Progress on the Mechanism of Cardiotoxic Side Effects of Anthracycline Drugs and Traditional Chinese Medicine Treatment[J]. Journal of Shandong First Medical University (Shandong Academy of Medical Sciences)(山东第一医科大学/山东省医学科学院学报), 2024, 45(1): 51-58. [3] BODAI BI, TUSO P.Breast Cancer Survivorship: a Comprehensive Review of Long-Term Medical Issues and Lifestyle Recommendations[J]. Perm J, 2015, 19(2): 48-79. [4] CROZIER JA, SWAIKA A, MORENO-ASPITIA A.Adjuvant Chemotherapy in Breast Cancer: to Use or Not to Use, the Anthracyclines[J]. World J Clin Oncol, 2014, 5(3): 529-538. [5] ZENG J, SHEN WS, DENG LC, et al.The Effect and Possible Mechanism of Jingtian Danxiong Decoction in Preventing the Cardiotoxicity Caused by Anthracycline Chemotherapy Drugs in Breast Cancer Patients[J]. Guangxi Medical Journal(广西医学), 2023, 45(13): 1568-1572. [6] WANG D, HUANG K, GUO SZ.Research Progress on Attenuation of Traditional Chinese Medicine Causing Cardiotoxicity and Traditional Chinese Medicine for Preventing and Treating Cardiotoxicity[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2022, 47(1): 18-23. [7] CHEN YP, ZHANG YP, SUN CS.Exploration on the Cardiac Protection Effect of Self-Designed Baoxin Decoction for Breast Cancer Patients Undergoing Chemotherapy with Anthracycline Drugs[J]. Sichuan Journal of Traditional Chinese Medicine(四川中医), 2021, 39(10): 147-150. [8] JIANG XQ.Clinical Research on Sanhuang Decoction in Improving the Symptoms of Cardiotoxicity of Anthracycline Drugs[D]. Nanjing: Nanjing University of Traditional Chinese Medicine(南京中医药大学), 2016. [9] XIE XQ, CHEN Y, LI J.Research on the Intervention of Warming Yang and Tonifying qi Method on the Cardiotoxicity of Anthracycline Chemotherapy Drugs[J]. Modern Journal of Integrated Traditional Chinese and Western Medicine(现代中西医结合杂志), 2023, 32(6): 786-791. [10] LI TD, HAN DY, FU XS, et al.The Influence of Wenxin Zhigancao Decoction on the Cardiotoxicity Related to Doxorubicin Chemotherapy in Breast Cancer[J]. Information on Traditional Chinese Medicine(中医药信息), 2023, 40(7): 67-70, 76. [11] LONG HD, LIN YE, LIANG BS, et al.The Influence of Zhigancao Decoction on the Heart of Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy with Doxorubicin[J]. China Prescription Drug(中国处方药), 2014(6): 7-8, 9. [12] MA JA, JIA XJ, QIU ZH, et al.The Protection of Compound Danshen Dripping Pills on the Cardiotoxicity of Chemotherapy and Radiotherapy for Breast cancer[J]. Journal of Clinical Research in Medicine(医学临床研究), 2006(7): 1160-1161. [13] MAO XW, YANG QJ, JI XH, et al.Clinical Observation of Buyang Huanwu Decoction Combined with Modifications to Prevent the Cardiotoxicity Caused by Chemotherapy with Anthracycline Drugs in Breast Cancer[J]. World of Health Preservation(养生大世界), 2021(20): 290-291. [14] SHEN XY, YUAN P.Clinical Observation of Modified Zhigancao Decoction on Cardiotoxicity Caused by Breast Cancer Chemotherapy and Analysis of Its Protective Effect on Cardiac Function[J]. Oncology Progress(癌症进展), 2018, 16(1): 106-109. [15] SUN YH, XU HS, ZHANG YY.The Influence of Self-Designed Shenmai Yangxin Decoction Combined with Creatine Phosphate on Oxygen Free Radicals and Cardiac Function of Breast Cancer Patients Receiving CAF Chemotherapy Regimen[J]. Modern Journal of Integrated Traditional Chinese and Western Medicine(现代中西医结合杂志), 2017, 26(23): 2528-2531. [16] WANG F.Clinical Research on Zhigancao Decoction in Preventing Cardiotoxicity Caused by Anthracycline Chemotherapy[D]. Shihezi: Shihezi University(石河子大学), 2015. [17] WU LJ, CHANG DH, ZHANG YM, et al.The Protective Effect of Yixin Buqi Decoction on the Cardiotoxicity Caused by Anthracycline Chemotherapy Drugs in Breast Cancer Patients[J]. Zhejiang Journal of Traditional Chinese Medicine(浙江中医杂志), 2021, 56(7): 500. [18] XUE JX.Clinical and Experimental Research of the Qi-invigorating and Blood-activating Prescription in Regulating the Body’s Oxidative Stress to Improve the Cardiotoxicity of Chemotherapy in breast cancer patients[D]. Nanjing: Nanjing University of Traditional Chinese Medicine(南京中医药大学), 2015. [19] WANG XC, GONG AM.Observation on the Curative Effect of Compound Danshen Dripping Pills in Treating Cardiotoxicity Caused by Chemotherapy with Breast Cancer CAF Regimen[J]. Henan Journal of Oncology(河南肿瘤学杂志), 2004(4): 290-291. [20] ZHANG WH.The Effect and Safety of Zhigancao Decoction Combined with TAC Chemotherapy Regimen in the Treatment of Breast Cancer[J]. Clinical Medicine(临床医学), 2021, 41(5): 122-124. [21] ZHOU J, YAO C, BIAN WH, et al.Clinical Observation of Sanhuang Antioxidant Prescription in Improving the Cardiotoxicity of Anthracycline Chemotherapy After Breast Cancer Surgery[J]. Journal of Liaoning University of Traditional Chinese Medicine(辽宁中医药大学学报), 2016, 18(7): 154-157. [22] CAO SH.Clinical Observation of Honghuang Decoction in Improving the Early Cardiotoxicity of Anthracycline Drugs Based on Regulating the Inflammatory Response[D]. Nanjing: Nanjing University of Traditional Chinese Medicine(南京中医药大学), 2020. [23] DONG LH, ZHANG H.Clinical Study of the Spleen-Strengthening and Kidney-Tonifying Prescription in Reducing the Cardiotoxicity of Postoperative Chemotherapy and Improving the Quality of Life of Breast Cancer Patients with Spleen-Kidney Deficiency Syndrome[J]. Journal of Hunan Normal University (Medical Edition)(湖南师范大学学报医学版), 2017, 14(5): 55-60. [24] FU ZH, KONG TD, CHEN L, et al.The Preventive Effect of Yiqi Huoxue Yangxin Decoction on Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients[J]. Journal of Traditional Chinese Medicine(中医学报), 2018, 33(9): 1619-1622. [25] GUO L, LUO YH, QIU J, et al.The Preventive Effect of Xin Yuan Capsule on Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients[J]. Journal of Gansu College of Traditional Chinese Medicine(甘肃中医学院学报), 2013, 30(4): 28-29. [26] HE NN, WANG QL, CHEN Y.The Clinical Effect of Tongyang Quyu Chinese Medicine in the Adjuvant Chemotherapy of Her-2 Positive Breast Cancer[J]. China Medical Herald(中国医药导报), 2017, 14(25): 89-93. [27] HU WL, ZHANG Y, WANG JZ, et al.The Clinical Observation of Modified Shengmai Powder and Gualou Xiebai Banxia Decoction in Preventing Cardiotoxicity Caused by Doxorubicin[J]. Chinese Journal of Traditional Chinese Medicine Science and Technology(中国中医药科技), 2014, 21(3): 318-320. [28] XIE XQ, JIANG Y.The Clinical Study of Yiqi Baoxin Decoction in Reducing the Cardiotoxicity of Breast Cancer Patients after Chemotherapy[J]. World Journal of Integrated Traditional and Western Medicine(世界中西医结合杂志), 2018, 13(10): 1396-1398. [29] LE YZ, BIAN WH, YAO C, et al.The Effect of Sanhuang Decoction on the Prevention and Treatment of Chemotherapy-Induced Cardiotoxicity in Breast Cancer Patients[J]. Chinese Journal of Gerontology(中国老年学杂志), 2016, 36(7): 1629-1632. [30] LI QH, WANG N, PAN SY, et al.The Clinical Study of Shenling Guben Pills in Preventing Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients[J]. Journal of Hubei University of Chinese Medicine(湖北中医药大学学报), 2017, 19(6): 21-25. [31] LIANG H, WANG YQ, LI YM, et al.The Clinical Study of Traditional Chinese Medicine in Reducing the Cardiotoxicity of Breast Cancer Patients After chemotherapy[J]. Sichuan Journal of Traditional Chinese Medicine(四川中医), 2013, 31(6): 83-85. [32] LIN GH, ZHANG J.The Effect of Buxue Yangxin Kangai Decoction on the Prevention and Treatment of Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients[J]. Journal of Liaoning University of Traditional Chinese Medicine(辽宁中医药大学学报), 2015, 17(9): 171-173. [33] LIN SZ.The Clinical Analysis and Mechanism Study of Zhigancao Decoction in Improving Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients[J]. Chinese and Foreign Medical Treatment(中外医疗), 2019, 38(25): 173-175. [34] LIU HM, LIU SZ, HUANG WJ, et al.The Application and Prognosis of Wenxin Granules in Breast Cancer Patients with Anthracycline-Induced Cardiotoxicity[J]. Chinese Journal of Modern Drug Application(中国现代药物应用), 2017, 11(8): 123-124. [35] LIU M.The Clinical Observation of Yangxin Fuyuan Decoction in Preventing Anthracycline-induced Cardiotoxicity in Breast Cancer Patients[D]. Jinan: Shandong University of Traditional Chinese Medicine(山东中医药大学), 2020. [36] LONG HD, LIN YE, LIANG SX, et al.The Clinical Observation of Tongmai Sini Decoction in the Prevention and Treatment of Early Myocardial Injury after Chemotherapy in Breast Cancer Patients[J]. Chinese Medical Innovation(中国医学创新), 2019, 16(25): 126-130. [37] OUYANG QF, YANG N, GUO JJ, et al.The Clinical Observation of Jianxin Granules in Improving Subclinical Cardiotoxicity of Anthracycline in Breast cancer Patients[J]. Fujian Medical Journal(福建医药杂志), 2021, 43(4): 44-47, 182. [38] QI ZH, HAN T, LIU ZZ, et al.The Effect of Modified Danggui Yangxin Decoction on Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients[J]. Journal of Trauma and Critical Care Medicine(创伤与急危重病医学), 2015, 3(3): 174-176. [39] SHAO Y, HAN F.The Clinical Observation of Qiliqiangxin Capsules in Preventing Cardiotoxicity Caused by Epirubicin in Breast Cancer Patients[J]. Journal of Cardiovascular Disease Prevention and Treatment(心血管病防治知识), 2023, 13(4): 19-21. [40] WANG W, LI Z, LI K.The Clinical Study of Yiqi Yangxin Decoction in the Prevention of Anthracycline-Induced Cardiotoxicity in Breast Cancer patients[J]. Chinese Journal of Traditional Chinese Medicine Science and Technology(中华中医药学刊), 2015, 33(10): 2535-2537. [41] XU GQ, XU Y, HU SF, et al.The Protective Effect of Wenxin Granules on Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients[J]. Journal of Nanchang University (Medical Edition)(南昌大学学报医学版), 2018, 58(2): 57-59, 63. [42] XU XY.The Clinical Observation of Sini Decoction in Preventing Acute Cardiotoxicity of Anthracycline in Breast Cancer Patients[J]. Chinese Medicine Guide(中国医药指南), 2017, 15(19): 198-199. [43] YANG Y, HUO YQ, XU L.The Clinical Observation of Yiqi Huoxue Tongluo Decoction in Preventing Anthracycline-induced Cardiotoxicity in Breast Cancer Patients[J]. Journal of Traditional Chinese Medicine(名医), 2019(7): 262. [44] YAO SQ, ZHOU L.The Clinical Study of Yiqi Huoxue Compound Mixture in Preventing Epirubicin-Induced Cardiotoxicity[J]. Journal of Qiqihar Medical University(齐齐哈尔医学院学报), 2017, 38(17): 2009-2011. [45] ZHANG MX.The Clinical Study of Sini Decoction in Preventing acute Cardiotoxicity of Anthracycline in Breast Cancer Patients[D]. Guangzhou: Guangzhou University of Traditional Chinese Medicine(广州中医药大学), 2014. [46] ZHANG XF, QIAO CX, CHENG XF, et al.The Protective Effect of Shengmai Powder Modified on Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients[J]. Liaoning Journal of Traditional Chinese Medicine(辽宁中医杂志), 2016, 43(11): 2307-2310. [47] ZHAO QX.The Clinical Study of Honghuang Decoction in Improving Anthracycline-Induced Cardiotoxicity by Regulating Trimethylamine-N-oxide Level[D]. Nanjing: Nanjing University of Traditional Chinese Medicine(南京中医药大学), 2022. [48] XUE JX, BIAN WH, YAO C.Meta-analysis of Curative Effects of Traditional Chinese Herbal Decoction on Breast Carcinoma Patients with Doxorubicin-induced Cardiotoxicity[J]. World Science and Technology - Modernization of Traditional Chinese Medicine(世界科学技术-中医药现代化), 2018, 20(6): 922-928. [49] LI SF, LI C, YU RL, et al.Network Meta-analysis of Traditional Chinese Medicine Decoctions for Cardiotoxicity Induced by Anthracycline Chemotherapy in Patients with Breast Cancer[J]. World Science and Technology - Modernization of Traditional Chinese Medicine(世界科学技术-中医药现代化), 2022, 24(1): 183-194. [50] XIA YY, JIANG CM, SUN C, et al.The Effect of Tanshinone IIA on Oxidative Stress and Apoptosis Factor Expression in Peritoneal Mesothelial Cells Induced by Peritoneal Dialysis Fluid[J]. Journal of Southeast University (Medical Edition)(东南大学学报医学版), 2013, 32(1): 36-41. [51] ZHNG Q, FENG Y, XU DS, et al.The Protective Effect of Ophiopogon Japonicus Polysaccharide MDG-1 on Experimental Myocardial Ischemia in Rats[J]. Chinese Journal of Integrated Traditional and Western Medicine(中国中西医结合杂志), 2007(12): 1116-1120. |
[1] | LIN Lu, ZHAN Luchuan, LIU Xiaoqi, LIU Ju'e, WANG Laiyou, ZENG Ying, LAI Weihua. Establish triggers for active monitoring of digoxin adverse events based on the China hospital pharmacovigilance system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(9): 1039-1043. |
[2] | SUN Yixin, NIE Xiaolu, WANG Xiaoling, GUO Peng. Comparative research on active post-marketing drug safety surveillance systems worldwide based on real-world data [J]. Chinese Journal of Pharmacovigilance, 2024, 21(8): 892-899. |
[3] | WEI Fenfang, WU Wenyu, LI Limin, TANG Biyu, WU Jianru. Foreign methods for benefit-risk assessment of pharmaceutical products [J]. Chinese Journal of Pharmacovigilance, 2024, 21(8): 900-905. |
[4] | ZHANG Jing, ZHANG Kai, YI Zhanmiao. Efficacy and safety of salvianolic acid preparations for adjuvant therapy on related diseases of coronary heart disease, angina and cerebral infarction: a systematic review [J]. Chinese Journal of Pharmacovigilance, 2024, 21(8): 910-915. |
[5] | LIU Qian, LI Bo, SHU Xinyang. Lanqin oral liquid combined with antibacterial drugs for the treatment of acute tonsillitis: a systematic review and Meta-analysis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(8): 916-920. |
[6] | WANG Dan, DONG Duo, TIAN Chunhua. Course of development of pharmocovigilance systems in China [J]. Chinese Journal of Pharmacovigilance, 2024, 21(7): 735-740. |
[7] | SHAO Bo, GUO Xiaoxin. Review of pharmacovigilance of traditional Chinese medicine [J]. Chinese Journal of Pharmacovigilance, 2024, 21(7): 741-745. |
[8] | ALATENG Hua, WANG Zhenxing, ZHANG Xiaomeng, SHI Wei, XI Chengwei, WANG Conghui, WANG Liqun, ZHANG Bing. Mining and analysis of cardiac disorders risk signals based on adverse drug reaction monitoring data [J]. Chinese Journal of Pharmacovigilance, 2024, 21(7): 752-758. |
[9] | LIU Yadi, ZHANG Xiaomeng, CAI Haili, CHEN Siying, WANG Yu, ZHANG Bing. Traditional Chinese medicine for prevention and treatment of adriamycin cardiotoxicity and an empirical study of evidence elements [J]. Chinese Journal of Pharmacovigilance, 2024, 21(7): 759-764. |
[10] | CAI Haili, ZHANG Xiaomeng, LIU Yadi, LIU Shujia, GAO Fujun, WANG Yu, ZHANG Bing. Progress in construction and evaluation of a drug-induced cardiotoxicity model [J]. Chinese Journal of Pharmacovigilance, 2024, 21(7): 765-770. |
[11] | ZHOU Xiuli, LIU Baosheng, MA Wenming, WANG Qi, WANG Yang, ZHAO Shipeng. Clinical use of cinobufagin preparations in cancer patients [J]. Chinese Journal of Pharmacovigilance, 2024, 21(7): 791-797. |
[12] | ALATENG Hua, GAO Lei, ZHANG Xiaomeng, ZHANG Bing. Exploring the scientific connotation of Mongolian Medicine pharmacovigilance based on ancient Mongolian Medical literature [J]. Chinese Journal of Pharmacovigilance, 2024, 21(6): 677-682. |
[13] | WANG Chunnan, QIN Shiru, ZHANG Meng, SONG Haibo, LIU Junchang, LI Ge, SUN Feng. Evaluation of drug safety with multicenter real-world data [J]. Chinese Journal of Pharmacovigilance, 2024, 21(6): 703-708. |
[14] | SU Xiaohan, ZENG Jiao, LI Xue, LIU Lixin, HOU Lingmi, LI Jinsui. Adverse events of abemaciclib in breast cancer patients based on US FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(5): 580-586. |
[15] | LI haiyan, YANG Zhongxu, LIU Yuekun, WANG Lihong. Pharmaceutical care of serious adverse reactions due to methotrexate treatment of ectopic pregnancy [J]. Chinese Journal of Pharmacovigilance, 2024, 21(4): 454-456. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||